BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11723222)

  • 1. Dopamine D2 receptor-induced heterologous sensitization of adenylyl cyclase requires Galphas: characterization of Galphas-insensitive mutants of adenylyl cyclase V.
    Watts VJ; Taussig R; Neve RL; Neve KA
    Mol Pharmacol; 2001 Dec; 60(6):1168-72. PubMed ID: 11723222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
    Watts VJ; Neve KA
    Mol Pharmacol; 1996 Oct; 50(4):966-76. PubMed ID: 8863843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells.
    Johnston CA; Beazely MA; Vancura AF; Wang JK; Watts VJ
    J Neurochem; 2002 Sep; 82(5):1087-96. PubMed ID: 12358756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.
    Cumbay MG; Watts VJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1201-9. PubMed ID: 11356947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using molecular tools to dissect the role of Galphas in sensitization of AC1.
    Vortherms TA; Nguyen CH; Berlot CH; Watts VJ
    Mol Pharmacol; 2004 Dec; 66(6):1617-24. PubMed ID: 15361543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of beta gamma subunits in transducing enhanced activity of the type VI isoform.
    Thomas JM; Hoffman BB
    Mol Pharmacol; 1996 May; 49(5):907-14. PubMed ID: 8622641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
    Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG
    Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2 dopamine receptor-induced sensitization of adenylyl cyclase type 1 is G alpha(s) independent.
    Vortherms TA; Nguyen CH; Bastepe M; Jüppner H; Watts VJ
    Neuropharmacology; 2006 Apr; 50(5):576-84. PubMed ID: 16376953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic agonists induce heterologous sensitization of adenylate cyclase in NS20Y-D(2L) cells.
    Johnston CA; Cumbay MG; Vortherms TA; Watts VJ
    FEBS Lett; 2001 May; 497(2-3):85-9. PubMed ID: 11377418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors.
    Watts VJ; Vu MN; Wiens BL; Jovanovic V; Van Tol HH; Neve KA
    Psychopharmacology (Berl); 1999 Jan; 141(1):83-92. PubMed ID: 9952069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor.
    Robinson SW; Caron MG
    Mol Pharmacol; 1997 Sep; 52(3):508-14. PubMed ID: 9281614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine D(2) receptor is expressed and sensitizes adenylyl cyclase activity in airway smooth muscle.
    Mizuta K; Zhang Y; Xu D; Masaki E; Panettieri RA; Emala CW
    Am J Physiol Lung Cell Mol Physiol; 2012 Feb; 302(3):L316-24. PubMed ID: 21964403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous stimulation of GABA and beta adrenergic receptors stabilizes isotypes of activated adenylyl cyclase heterocomplex.
    Robichon A; Tinette S; Courtial C; Pelletier F
    BMC Cell Biol; 2004 Jun; 5():25. PubMed ID: 15189569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenoceptor control of cardiac adenylyl cyclase during development: agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization.
    Giannuzzi CE; Seidler FJ; Slotkin TA
    Brain Res; 1995 Oct; 694(1-2):271-8. PubMed ID: 8974654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors.
    Watts VJ; Neve KA
    Mol Pharmacol; 1997 Aug; 52(2):181-6. PubMed ID: 9271339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of adenylate cyclase induced by a dopamine D2 receptor mutant: inverse agonism by D2 receptor antagonists.
    Bullock CM; Li C; Li M; Bermak JC; Zhou QY
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Oct; 25(7):1387-402. PubMed ID: 11513354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca(2+)-dependent sensitization of adenylyl cyclase activity.
    Rousseau G; Haddad PS; Gallo-Payet N; Bouvier M
    Eur J Pharmacol; 2001 Jun; 422(1-3):53-60. PubMed ID: 11430913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Galphas stimulation.
    Chen Y; Harry A; Li J; Smit MJ; Bai X; Magnusson R; Pieroni JP; Weng G; Iyengar R
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14100-4. PubMed ID: 9391159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual sensitization of the adrenergic system in early myocardial ischemia: independent regulation of the beta-adrenergic receptors and the adenylyl cyclase.
    Strasser RH; Krimmer J; Braun-Dullaeus R; Marquetant R; Kübler W
    J Mol Cell Cardiol; 1990 Dec; 22(12):1405-23. PubMed ID: 1965211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.